Shyam Prabhakaran to Tissue Plasminogen Activator
This is a "connection" page, showing publications Shyam Prabhakaran has written about Tissue Plasminogen Activator.
Connection Strength
6.437
-
Door-In-Door-Out Process Times at Primary Stroke Centers in Chicago. Ann Emerg Med. 2021 11; 78(5):674-681.
Score: 0.721
-
National Practice Patterns of Obtaining Informed Consent for Stroke Thrombolysis. Stroke. 2018 03; 49(3):765-767.
Score: 0.561
-
Racial disparities in refusal of stroke thrombolysis in Chicago. Neurology. 2018 01 30; 90(5):e359-e364.
Score: 0.556
-
Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times. Circ Cardiovasc Qual Outcomes. 2016 09; 9(5):585-92.
Score: 0.508
-
Intervention for Acute Stroke--Reply. JAMA. 2015 Aug 11; 314(6):626-7.
Score: 0.471
-
Acute stroke intervention: a systematic review. JAMA. 2015 Apr 14; 313(14):1451-62.
Score: 0.461
-
Prehospital triage to primary stroke centers and rate of stroke thrombolysis. JAMA Neurol. 2013 Sep 01; 70(9):1126-32.
Score: 0.412
-
Response to the letter by Lee et al. J Stroke Cerebrovasc Dis. 2013 Aug; 22(6):894.
Score: 0.383
-
Intravenous thrombolysis in a stroke patient taking dabigatran. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):916.e11-2.
Score: 0.377
-
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2010 May; 67(5):559-63.
Score: 0.324
-
Challenges to Door-In-Door-Out Time Thresholds for Patients With Stroke-Reply. JAMA. 2023 12 19; 330(23):2306.
Score: 0.210
-
Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke. Neurology. 2022 04 19; 98(16):e1596-e1604.
Score: 0.186
-
Presentation, Evaluation, Management, and Outcomes of Acute Stroke in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2018; 51(1-2):104-112.
Score: 0.144
-
Cincinnati Prehospital Stroke Scale Can Identify Large Vessel Occlusion Stroke. Prehosp Emerg Care. 2018 May-Jun; 22(3):312-318.
Score: 0.139
-
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Feb; 47(2):581-641.
Score: 0.121
-
Academic-Community Hospital Comparison of Vulnerabilities in Door-to-Needle Process for Acute Ischemic Stroke. Circ Cardiovasc Qual Outcomes. 2015 Oct; 8(6 Suppl 3):S148-54.
Score: 0.119
-
Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Sep; 23(8):2139-2144.
Score: 0.110
-
Telestroke in an urban setting. Telemed J E Health. 2014 Sep; 20(9):855-7.
Score: 0.109
-
Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic stroke. Cerebrovasc Dis. 2014; 37(5):356-63.
Score: 0.109
-
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012 Sep; 43(9):2293-9.
Score: 0.095
-
Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke. 2012 Mar; 43(3):875-7.
Score: 0.091
-
Should TIA patients be hospitalized or referred to a same-day clinic?: a decision analysis. Neurology. 2011 Dec 13; 77(24):2082-8.
Score: 0.091
-
An update on acute ischemic stroke therapies. Compr Ther. 2009; 35(2):72-80.
Score: 0.075
-
Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology. 2007 Mar 13; 68(11):842-8.
Score: 0.066